Results 171 to 180 of about 110,071 (192)

COVID-19 mRNA vaccines: Platforms and current developments

Molecular Therapy, 2022
Gabor Tamás SZABÓ, Irena Vlatkovic
exaly  

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

New England Journal of Medicine, 2021
Mark G Thompson, Allison L Naleway, Harmony L Tyner   +2 more
exaly  

Vaccination with Messenger RNA (mRNA)

2008
Both DNA and mRNA can be used as vehicles for gene therapy. Because the immune system is naturally activated by foreign nucleic acids thanks to the presence of Toll-like Receptors (TLR) in endosomes (TLR3, 7, and 8 detect exogenous RNA, while TLR9 can detect exogenous DNA), the delivery of foreign nucleic acids usually induces an immune response ...
openaire   +2 more sources

mRNA vaccines manufacturing: Challenges and bottlenecks

Vaccine, 2021
Sara Sousa Rosa, Duarte M F Prazeres, Ana M Azevedo   +2 more
exaly  

Suppressing autoimmunity with mRNA vaccines

Nature Reviews Drug Discovery, 2021
openaire   +2 more sources

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans

New England Journal of Medicine, 2022
Barbra A Dickerman, Hanna Gerlovin, Arin L Madenci   +2 more
exaly  

mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids

Advanced Functional Materials, 2022
Yupei Zhang, Xing Duan, Yuquan Wei
exaly  

mRNA Vaccines

2022
openaire   +1 more source

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

Frontiers in Immunology, 2023
Bolin Wang, Shengnan Xu, Jinming Yu
exaly  

Thoughts on mRNA Vaccine Response

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2023
openaire   +2 more sources